So true my emperor. We are at the early stages of what appears to be a year full of positive announcements. The upcoming quarterly will not be disappointing to me as I am realistic . I know the revenue will be small,as we are expecting sales revenue from one market alone,and I don't expect too much,but would love to know others estimates that are in the know . As we introduce more products into the market then the revenue stream will become significant. In a few years time,imho,we should all be satisfied holders. Let's also not forget coty and my favorite, gsk oral. How lucky are we to have our technology incorporated with products that are already pulling in significant revenue.
In short It's good to be a holder and still have the opportunity to increase your holding before it's too expensive to do so.
- Forums
- ASX - By Stock
- WFL
- (OBJ) Our Blastoff Justified
(OBJ) Our Blastoff Justified, page-4
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online